Pedro Cunha
About Pedro Cunha
Pedro Cunha is a Clinical Project Manager at Aimmune Therapeutics, where he has worked since 2020. He has extensive experience in clinical research, having held various positions at several organizations over the past 17 years.
Work at Aimmune Therapeutics
Pedro Cunha has been employed at Aimmune Therapeutics since 2020, currently holding the position of Clinical Project Manager in London, England. Prior to this role, he served as Lead Clinical Research Associate (CRA) from 2016 to 2020 at the company's Kings Cross location. His experience at Aimmune Therapeutics encompasses project management and oversight of clinical trials, contributing to the organization's mission in advancing therapies for food allergies.
Previous Experience in Clinical Research
Before joining Aimmune Therapeutics, Pedro Cunha gained extensive experience in clinical research across various organizations. He worked at Novartis as a Senior CRA from 2014 to 2016, and previously held roles at INC Research as a Clinical Research Associate III from 2012 to 2014, and at ICON plc as a Clinical Research Associate II from 2011 to 2012. His early career included positions at PAREXEL and CROfessionals, where he served as a Clinical Research Associate I, and at Chiltern as a Project Research Administrator.
Education and Expertise
Pedro Cunha's educational background and expertise in clinical research are foundational to his career. His roles have involved significant responsibilities in managing clinical trials, ensuring compliance with regulatory standards, and collaborating with cross-functional teams. His progression from Project Research Administrator to Clinical Project Manager reflects his deepening knowledge and skills in the clinical research field.
Career Timeline
Pedro Cunha's career in clinical research spans over a decade, beginning in 2006 at Chiltern. He transitioned through various roles, including Clinical Research Associate positions at CROfessionals, PAREXEL, ICON plc, and INC Research, before advancing to a Senior CRA role at Novartis. His tenure at Aimmune Therapeutics marks a significant phase in his career, where he has taken on leadership responsibilities in clinical project management.